Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGenestudy (Q57611798)
Jump to navigation
Jump to search
scientific article published on 01 January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGenestudy |
scientific article published on 01 January 2009 |
Statements
Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study (English)
R Schnabel
AtheroGene Investigators
M C Alessi
T Godefroy
V Nicaud
T Munzel
C Bickel
H J Rupprecht
E Lubos
T Zeller
I Juhan-Vague
S Blankenberg
L Tiret